Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects.
Gauvreau GM, Boulet LP, Schmid-Wirlitsch C, Côté J, Duong M, Killian KJ, Milot J, Deschesnes F, Strinich T, Watson RM, Bredenbröker D, O'Byrne PM. Gauvreau GM, et al. Among authors: milot j. Respir Res. 2011 Oct 26;12(1):140. doi: 10.1186/1465-9921-12-140. Respir Res. 2011. PMID: 22029856 Free PMC article. Clinical Trial.
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
O'Byrne PM, van der Linde J, Cockcroft DW, Gauvreau GM, Brannan JD, Fitzgerald M, Watson RM, Milot J, Davis B, O'Connor M, Hart L, Korducki L, Hamilton AL, Boulet LP. O'Byrne PM, et al. Among authors: milot j. J Allergy Clin Immunol. 2009 Dec;124(6):1217-21. doi: 10.1016/j.jaci.2009.08.047. J Allergy Clin Immunol. 2009. PMID: 20004781 Clinical Trial.
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.
Gauvreau GM, Arm JP, Boulet LP, Leigh R, Cockcroft DW, Davis BE, Mayers I, FitzGerald JM, Dahlen B, Killian KJ, Laviolette M, Carlsten C, Lazarinis N, Watson RM, Milot J, Swystun V, Bowen M, Hui L, Lantz AS, Meiser K, Maahs S, Lowe PJ, Skerjanec A, Drollmann A, O'Byrne PM. Gauvreau GM, et al. Among authors: milot j. J Allergy Clin Immunol. 2016 Oct;138(4):1051-1059. doi: 10.1016/j.jaci.2016.02.027. Epub 2016 Apr 7. J Allergy Clin Immunol. 2016. PMID: 27185571 Clinical Trial.
Comparative prevalence of co-morbidities in smoking and non-smoking asthma patients with incomplete reversibility of airway obstruction, non-smoking asthma patients with complete reversibility of airway obstruction and COPD patients.
Nadeau M, Boulay MÈ, Milot J, Lepage J, Bilodeau L, Maltais F, Boulet LP. Nadeau M, et al. Among authors: milot j. Respir Med. 2017 Apr;125:82-88. doi: 10.1016/j.rmed.2017.03.005. Epub 2017 Mar 6. Respir Med. 2017. PMID: 28340867 Free article.
Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma.
Bernstein DI, Cartier A, Côté J, Malo JL, Boulet LP, Wanner M, Milot J, L'Archevéque J, Trudeau C, Lummus Z. Bernstein DI, et al. Among authors: milot j. Am J Respir Crit Care Med. 2002 Aug 15;166(4):445-50. doi: 10.1164/rccm.2109018. Am J Respir Crit Care Med. 2002. PMID: 12186818
111 results